242 related articles for article (PubMed ID: 36516487)
21. Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors.
Yan W; Xu T; Zhu H; Yu J
Onco Targets Ther; 2020; 13():719-731. PubMed ID: 32158224
[TBL] [Abstract][Full Text] [Related]
22. Investigation of white blood cell characteristics in cerebrospinal fluid samples at pediatric brain tumor diagnosis.
Greer HR; Miller K; Samay S; Nellan A; Green AL
J Neurooncol; 2022 Sep; 159(2):301-308. PubMed ID: 35731362
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification.
Zuccato JA; Patil V; Mansouri S; Voisin M; Chakravarthy A; Shen SY; Nassiri F; Mikolajewicz N; Trifoi M; Skakodub A; Zacharia B; Glantz M; De Carvalho DD; Mansouri A; Zadeh G
Neuro Oncol; 2023 Aug; 25(8):1452-1460. PubMed ID: 36455236
[TBL] [Abstract][Full Text] [Related]
24. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
Sasayama T; Nakamizo S; Nishihara M; Kawamura A; Tanaka H; Mizukawa K; Miyake S; Taniguchi M; Hosoda K; Kohmura E
Neuro Oncol; 2012 Mar; 14(3):368-80. PubMed ID: 22156547
[TBL] [Abstract][Full Text] [Related]
25. Utilization of Cerebrospinal Fluid Proteome Analysis in the Diagnosis of Meningioma: A Systematic Review.
Choudhary R; Elabbas A; Vyas A; Osborne D; Chigurupati HD; Abbas LF; Kampa P; M H F; Sarwar H; Alfonso M
Cureus; 2021 Dec; 13(12):e20707. PubMed ID: 34966627
[TBL] [Abstract][Full Text] [Related]
26. Is There a Role for Machine Learning in Liquid Biopsy for Brain Tumors? A Systematic Review.
Menna G; Piaser Guerrato G; Bilgin L; Ceccarelli GM; Olivi A; Della Pepa GM
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298673
[TBL] [Abstract][Full Text] [Related]
27. Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid.
Gu W; Rauschecker AM; Hsu E; Zorn KC; Sucu Y; Federman S; Gopez A; Arevalo S; Sample HA; Talevich E; Nguyen ED; Gottschall M; Nourbakhsh B; Gold CA; Cree BAC; Douglas VC; Richie MB; Shah MP; Josephson SA; Gelfand JM; Miller S; Wang L; Tihan T; DeRisi JL; Chiu CY; Wilson MR
JAMA Neurol; 2021 Nov; 78(11):1355-1366. PubMed ID: 34515766
[TBL] [Abstract][Full Text] [Related]
28. The Clinical Applications of Liquid Biopsies in Pediatric Brain Tumors: A Systematic Literature Review.
Greuter L; Frank N; Guzman R; Soleman J
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681663
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers of pediatric brain tumors.
Russell MD; Young AM; Karri SK
Front Pediatr; 2013 Mar; 1():7. PubMed ID: 24400253
[TBL] [Abstract][Full Text] [Related]
30. Molecular and Circulating Biomarkers of Brain Tumors.
Jelski W; Mroczko B
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34210107
[TBL] [Abstract][Full Text] [Related]
31. Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignancies.
Zorofchian S; Iqbal F; Rao M; Aung PP; Esquenazi Y; Ballester LY
J Clin Pathol; 2019 Apr; 72(4):271-280. PubMed ID: 30467241
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic role and dynamic changes in cerebrospinal fluid neopterin during treatment of patients with primary central nervous system lymphoma.
Geng M; Xiao H; Liu J; Song Y; Fu P; Cheng X; Zhang J; Wang G
Cancer Med; 2018 Aug; 7(8):3889-3898. PubMed ID: 29982995
[TBL] [Abstract][Full Text] [Related]
33. Liquid biopsy and tumor DNA/RNA detection in the cerebrospinal fluid of patients diagnosed with central nervous system glioma - A review article.
Borba LAB; Passos G; Oliveira I
Surg Neurol Int; 2023; 14():183. PubMed ID: 37292399
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid-based metabolomics to characterize different types of brain tumors.
Wang FX; Chen K; Huang FQ; Alolga RN; Ma J; Wu ZX; Fan Y; Ma G; Guan M
J Neurol; 2020 Apr; 267(4):984-993. PubMed ID: 31822990
[TBL] [Abstract][Full Text] [Related]
35. A systematic approach to the diagnosis of suspected central nervous system lymphoma.
Scott BJ; Douglas VC; Tihan T; Rubenstein JL; Josephson SA
JAMA Neurol; 2013 Mar; 70(3):311-9. PubMed ID: 23319132
[TBL] [Abstract][Full Text] [Related]
36. The "Liquid Biopsy": the Role of Circulating DNA and RNA in Central Nervous System Tumors.
Connolly ID; Li Y; Gephart MH; Nagpal S
Curr Neurol Neurosci Rep; 2016 Mar; 16(3):25. PubMed ID: 26838352
[TBL] [Abstract][Full Text] [Related]
37. Lessons from Epstein-Barr virus DNA detection in cerebrospinal fluid as a diagnostic tool for EBV-induced central nervous system dysfunction among HIV-positive patients.
Wang Y; Yang J; Wen Y
Biomed Pharmacother; 2022 Jan; 145():112392. PubMed ID: 34781140
[TBL] [Abstract][Full Text] [Related]
38. Pseudocholinesterase activity in cerebrospinal fluid as a biomarker of solid central nervous system tumors in children.
Mikecin L; Krizmaric M; Stepan Giljevic J; Gjurasin M; Kern J; Lenicek Krleza J; Popovic L
Croat Med J; 2013 Oct; 54(5):429-35. PubMed ID: 24170721
[TBL] [Abstract][Full Text] [Related]
39. Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies.
Shalaby T; Grotzer MA
Int J Mol Sci; 2015 Dec; 16(12):29103-19. PubMed ID: 26690130
[TBL] [Abstract][Full Text] [Related]
40. Liquid biopsy in central nervous system tumors: the potential roles of circulating miRNA and exosomes.
Aili Y; Maimaitiming N; Mahemuti Y; Qin H; Wang Y; Wang Z
Am J Cancer Res; 2020; 10(12):4134-4150. PubMed ID: 33414991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
